Total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017

This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market

Pune, India – February 15, 2018 /MarketersMedia/ —

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. The total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017.

Access this report at: https://www.themarketreports.com/report/global-oncolytic-virus-therapy-market-size-status-and-forecast-2025

Companies profiled in this report are Amgen, Oncolytics Biotech, Viralytics, Transgene Sa, Oncolys Biopharma, Targovax, Psioxus Therapeutics, Sillajen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, Tilt Biotherapeutics, Cold Genesys and more.

Analysis by Applications, this report focuses on consumption, market share and growth rate of Oncolytic Virus Therapy in each application, can be divided into
• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/924753

Table of Contents:
1 Oncolytic Virus Therapy Market Overview
2 Global Oncolytic Virus Therapy Market Competition by Manufacturers
3 Global Oncolytic Virus Therapy R&D Investment by Regions (2013-2018)
4 Global Oncolytic Virus Therapy Market Size by Regions (2013-2018)
5 Global Oncolytic Virus Therapy R&D Investment by Application
6 Analysis of Oncolytic Virus Therapy Industry Key Manufacturers
7 New Drugs Manufacturing Cost Analysis
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
10 Market Effect Factors Analysis
11 Global Oncolytic Virus Therapy Market Forecast (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source

Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/924753

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/total-investment-for-oncolytic-virus-therapy-developing-is-around-84-m-usd-in-2017/301684

For more information, please visit https://www.themarketreports.com/report/global-oncolytic-virus-therapy-market-size-status-and-forecast-2025

Source: MarketersMedia

Release ID: 301684